Aptose Biosciences Inc.
APS.TO
Price:
$0.54
Market Cap:
$7.21M
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. Its clinical programs include APTO-253, which is in Phase 1a/b clinical trial for the treatment of patients with relapsed or refractory blood cancers, including acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR MDS); and HM43239 that is in Phase 1/2 clinical trial to treat patients with relapsed or refractory AML. The company also develops luxeptinib, which is in Phase 1a/b clinical trial for treating patients with relapsed or refractory B-cell malignancies, including chronic lymphocytic...[Read more]
Industry
Biotechnology
IPO Date
1996-04-25
Stock Exchange
TSX
Ticker
APS.TO
The PE Ratio as of September 2024 (TTM) for Aptose Biosciences Inc. (APS.TO) is -0.09
According to Aptose Biosciences Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.09. This represents a change of -73.44% compared to the average of -0.34 of the last 4 quarters.
Aptose Biosciences Inc. (APS.TO) Historical PE Ratio (quarterly & annually)
How has APS.TO PE Ratio performed in the past?
The mean historical PE Ratio of Aptose Biosciences Inc. over the last ten years is -5.58. The current -0.09 PE Ratio has changed 61.38% with respect to the historical average. Over the past ten years (40 quarters), APS.TO's PE Ratio was at its highest in in the December 2023 quarter at -0.00. The PE Ratio was at its lowest in in the June 2022 quarter at -24.66.
Average
-5.58
Median
-3.59
Minimum
-19.40
Maximum
-0.33
Aptose Biosciences Inc. (APS.TO) PE Ratio by Quarter and Year
Discovering the peaks and valleys of Aptose Biosciences Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 938.98%
Maximum Annual PE Ratio = -0.33
Minimum Annual Increase = -98.28%
Minimum Annual PE Ratio = -19.40
| Year | PE Ratio | Change |
|---|---|---|
| 2023 | -0.33 | -98.28% |
| 2022 | -19.40 | 938.98% |
| 2021 | -1.87 | -71.55% |
| 2020 | -6.56 | -40.55% |
| 2019 | -11.04 | 400.89% |
| 2018 | -2.20 | -47.99% |
| 2017 | -4.24 | 242.58% |
| 2016 | -1.24 | -57.88% |
| 2015 | -2.94 | -50.68% |
| 2014 | -5.95 | 123.10% |
Aptose Biosciences Inc. (APS.TO) Average PE Ratio
How has APS.TO PE Ratio performed in the past?
The current PE Ratio of Aptose Biosciences Inc. (APS.TO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-7.20
5-year avg
-7.84
10-year avg
-5.58
Aptose Biosciences Inc. (APS.TO) PE Ratio vs. Peers
How is APS.TO’s PE Ratio compared to its peers?
Aptose Biosciences Inc.’s PE Ratio is greater than Medicenna Therapeutics Corp. (-5.70), greater than Oncolytics Biotech Inc. (-3.42), greater than IMV Inc. (-0.19), greater than BELLUS Health Inc. (-41.97), greater than Aeterna Zentaris Inc. (-0.10),
| Company | PE Ratio | Market cap |
|---|---|---|
| -5.70 | $155.90M | |
| -3.42 | $97.00M | |
| -0.19 | $13.12M | |
| -41.97 | $2.47B | |
| -0.10 | $25.38M |
Build a custom stock screener for Aptose Biosciences Inc. (APS.TO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aptose Biosciences Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Aptose Biosciences Inc. (APS.TO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Aptose Biosciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the PE Ratio?
How can you use the PE Ratio?
What is Aptose Biosciences Inc.'s PE Ratio?
How is the PE Ratio calculated for Aptose Biosciences Inc. (APS.TO)?
What is the highest PE Ratio for Aptose Biosciences Inc. (APS.TO)?
What is the 3-year average PE Ratio for Aptose Biosciences Inc. (APS.TO)?
What is the 5-year average PE Ratio for Aptose Biosciences Inc. (APS.TO)?
How does the current PE Ratio for Aptose Biosciences Inc. (APS.TO) compare to its historical average?